Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03247387 · ClinicalTrials.gov registry record
eOnOff - D1 Extension
A clinical trial, sponsored by Boston University.
- Completed
- Registry status
- 34
- Enrollment target
NCT03247387 is a clinical trial that has completed, run by Boston University. The registered enrollment target is 34 participants.
The verdict
NCT03247387 has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
Clinical assessments can only offer a snapshot of daily life with Parkinson's Disease, while wearable devices can offer immensely more information that can improve the understanding of this disease. With recent advancements in technology, investigators are now able to use watch-like devices to more effectively measure the symptoms of Parkinson's Disease outside of the doctor's office. The present study is designed to evaluate the usability, applicability, and interpretability of an electronic VA Patient Motor Diary (eON-OFF), MC10 BioStampRC actigraphy sensor, APDM actigraphy sensor and the GENEActiv Watch in persons with Parkinson's Disease. There is no placebo/control group.
Interventions
- DEVICE MC10 BioStampRC
- DEVICE APDM actigraphy device
- DEVICE GENEActiv watch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2017-05-02 |
| Est. Completion | 2019-01-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03247387
The ClinicalTrials.gov registry entry for NCT03247387 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which MC10 BioStampRC is the first listed.
NCT03247387 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03247387 about?
NCT03247387 is a clinical study titled "eOnOff - D1 Extension". Clinical assessments can only offer a snapshot of daily life with Parkinson's Disease, while wearable devices can offer immensely more information that can improve the understanding of this disease. With recent advancements in technology, investigators are now able to use watch-like devices to more ...
What is the current status of trial NCT03247387?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2017-05-02. Estimated completion is 2019-01-22.
What interventions are being tested in trial NCT03247387?
The interventions under investigation include: MC10 BioStampRC (DEVICE), APDM actigraphy device (DEVICE), GENEActiv watch (DEVICE).
Who is sponsoring clinical trial NCT03247387?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.